glp-1 and diabetes Glucagon-like peptide-1 Targeting GLP-1, GIP & GCG
Description
Patient safety issues in the GLP-1 space this week Patients seeking alternative sources for their semaglutide and tirzepatide injections need to know that the drugs these pharmacies sell to Americans are not the same as the ones Canadians take, and neither Health Canada nor the FDA are regulating them
doi: 10.1038/nature18646 96 PengQ.ChenX.LiangX.OuyangJ.WangQ.RenS.et al
White adults report the lowest usage at 10%
Studies on the long-term safety of GLP-1RAs suggest temporal and individualized variations in their clinical application
